Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Control Release ; 233: 208-19, 2016 07 10.
Article in English | MEDLINE | ID: mdl-27178810

ABSTRACT

Influenza infection typically initiates at respiratory mucosal surfaces. Induction of immune responses at the sites where pathogens initiate replication is crucial for the prevention of infection. We studied the adjuvanticity of GPI-anchored CCL28 co-incorporated with influenza HA-antigens in chimeric virus-like particles (cVLPs), in boosting strong protective immune responses through an intranasal (i.n.) route in mice. We compared the immune responses to that from influenza VLPs without CCL28, or physically mixed with soluble CCL28 at systemic and various mucosal compartments. The cVLPs containing GPI-CCL28 showed in-vitro chemotactic activity towards spleen and lung cells expressing CCR3/CCR10 chemokine receptors. The cVLPs induced antigen specific endpoint titers and avidity indices of IgG in sera and IgA in tracheal, lung, and intestinal secretions, significantly higher (4-6 fold) than other formulations. Significantly higher (3-5 fold) hemagglutination inhibition titers and high serum neutralization against H3N2 viruses were also detected with CCL28-containing VLPs compared to other groups. The CCL28-containing VLPs showed complete and 80% protection, when vaccinated animals were challenged with A/Aichi/2/1968/H3N2 (homologous) and A/Philippines/2/1982/H3N2 (heterologous) viruses, respectively. Thus, GPI-anchored CCL28 in influenza VLPs act as a strong immunostimulator at both systemic and mucosal sites, boosting significant cross-protection in animals against heterologous viruses across a large distance.


Subject(s)
Antigens, Viral/administration & dosage , Chemokines, CC/administration & dosage , GPI-Linked Proteins/administration & dosage , Hemagglutinins, Viral/administration & dosage , Influenza A Virus, H3N2 Subtype/immunology , Vaccines, Virus-Like Particle/administration & dosage , Viral Matrix Proteins/administration & dosage , Administration, Intranasal , Animals , Antibodies, Viral/immunology , Cell Line , Dogs , Female , Immunoglobulin A/immunology , Immunoglobulin G/immunology , Madin Darby Canine Kidney Cells , Mice, Inbred BALB C , Orthomyxoviridae Infections/prevention & control , Spodoptera
2.
EBioMedicine ; 5: 46-58, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27077111

ABSTRACT

Dendritic cells (DCs) are major antigen-presenting cells that can efficiently prime and cross-prime antigen-specific T cells. Delivering antigen to DCs via surface receptors is thus an appealing strategy to evoke cellular immunity. Nonetheless, which DC surface receptor to target to yield the optimal CD8(+) and CD4(+) T cell responses remains elusive. Herein, we report the superiority of CD40 over 9 different lectins and scavenger receptors at evoking antigen-specific CD8(+) T cell responses. However, lectins (e.g., LOX-1 and Dectin-1) were more efficient than CD40 at eliciting CD4(+) T cell responses. Common and distinct patterns of subcellular and intracellular localization of receptor-bound αCD40, αLOX-1 and αDectin-1 further support their functional specialization at enhancing antigen presentation to either CD8(+) or CD4(+) T cells. Lastly, we demonstrate that antigen targeting to CD40 can evoke potent antigen-specific CD8(+) T cell responses in human CD40 transgenic mice. This study provides fundamental information for the rational design of vaccines against cancers and viral infections.


Subject(s)
Antigen Presentation/immunology , CD40 Ligand/immunology , Dendritic Cells/immunology , Immunotherapy, Active , Lymphocyte Activation/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cell Differentiation/immunology , Humans , Lectins/immunology , Lectins, C-Type/immunology , Mice , Mice, Transgenic , Recombinant Fusion Proteins/immunology , Scavenger Receptors, Class E/immunology
3.
J Synchrotron Radiat ; 18(Pt 5): 743-6, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21862854

ABSTRACT

Liquid water produced in a polymer electrolyte membrane fuel cell experiences a freeze/thaw cycle when the cell is switched off and on while operating at ambient temperatures below freezing. This freeze/thaw cycle permanently deforms the polymer electrolyte membrane fuel cell capillary structures and reduces both the cell life and its ability to generate electric power. The X-ray tomography facility at the Pohang Accelerator Laboratory was used to observe the freeze/thaw effects on the gas diffusion layer (GDL), which is the thickest capillary layer in the cell. Morphological changes in the GDL under a water freeze/thaw cycle were observed. A scenario in which freeze/thaw cycles affect fuel cell performance is suggested based on images from X-ray tomography.

SELECTION OF CITATIONS
SEARCH DETAIL
...